Skip to main content
SpringerLink
Log in

Neue Aspekte in Diagnostik und Therapie des Endometriumkarzinoms

New aspects in diagnostics and treatment of endometrial cancer

  • Gynäkologie aktuell
  • Published:
Der Gynäkologe Aims and scope

A Kommentar to this article was published on 15 March 2022

A Kommentar to this article was published on 15 March 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Walker JL et al (2009) Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study LAP2. J Clin Oncol 27:5331–5336

    Article  PubMed  PubMed Central  Google Scholar 

  2. Zullo F, Falbo A, Palomba S (2012) Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 207:94–100

    Article  PubMed  Google Scholar 

  3. Ran L et al (2014) Comparison of robotic surgery with laparoscopy and laparotomy for treatment of endometrial cancer: a meta-analysis. PLoS One 9:e108361

    Article  PubMed  PubMed Central  Google Scholar 

  4. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO et al (2008) Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 109:11–18

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kang S, Yoo HJ, Hwang JH, Lim MC, Seo SS, Park SY (2011) Sentinel lymph node biopsy in endometrial cancer: meta-analysis of 26 studies. Gynecol Oncol 123:522–527

    Article  PubMed  Google Scholar 

  6. Khoury-Collado F, Glaser GE, Zivanovic O, Sonoda Y, Levine DA, Chi DS et al (2009) Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol Oncol 115:453–455

    Article  PubMed  Google Scholar 

  7. Leitao MM, Khoury-Collado F, Gardner G, Sonoda Y, Brown CL, Alektiar KM et al (2013) Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol 129:38–41

    Article  PubMed  Google Scholar 

  8. Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18:384–392

    Article  PubMed  Google Scholar 

  9. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67–73

    Article  Google Scholar 

  10. Talhouk A, Hoang LN, McConechy MK et al (2016) Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment. Gynecol Oncol 143:46–53

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ali-Ahmad HM, Rothe M, Mangat PA et al (2021) Pertuzumab plus trastuzumab (P+T) in patients (pts) with uterine cancer (UC) with ERBB2 or ERBB3 amplification, overexpression or mutation: results from the targeted agent and profiling utilization registry (TAPUR) study. J Clin Oncol 39(15):5508

    Article  Google Scholar 

  12. Green AK, Feinberg J, Makker V (2020) A review of immune checkpoint blockade therapy in endometrial cancer. Am Soc Clin Oncol Educ Book 40:1–7. https://doi.org/10.1200/EDBK_280503

    Article  PubMed  Google Scholar 

  13. Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M, Penel N, Hansen AR, Piha-Paul SA, Doi T, Gao B, Chung HC, Lopez-Martin J, Bang YJ, Frommer RS, Shah M, Ghori R, Joe AK, Pruitt SK, Diaz LA Jr. (2020) Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 38:1–10

    Article  CAS  PubMed  Google Scholar 

  14. Oaknin A, Tinker AV, Gilbert L, Samouëlian V, Mathews C, Brown J, Barretina-Ginesta MP, Moreno V, Gravina A, Abdeddaim C, Banerjee S, Guo W, Danaee H, Im E, Sabatier R (2020) Clinical activity and safety of the anti-programmed death 1 monoclonal antibody dostarlimab for patients with recurrent or advanced mismatch repair-deficient endometrial cancer: a nonrandomized phase 1 clinical trial. JAMA Oncol 6:1766–1772

    Article  PubMed  Google Scholar 

  15. Konstantinopoulos PA, Luo W, Liu JF, Gulhan DC, Krasner C, Ishizuka JJ, Gockley AA, Buss M, Growdon WB, Crowe H, Campos S, Lindeman NI, Hill S, Stover E, Schumer S, Wright AA, Curtis J, Quinn R, Whalen C, Gray KP, Penson RT, Cannistra SA, Fleming GF, Matulonis UA (2019) Phase II study of avelumab in patients with mismatch repair deficient and mismatch repair proficient recurrent/persistent endometrial cancer. J Clin Oncol 20:2786–2794

    Article  Google Scholar 

  16. Ackroyd SA, Huang ES, Kurnit KC, Lee NK (2021) Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: a Markov analysis. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2021.05.038

    Article  PubMed  PubMed Central  Google Scholar 

  17. Dosil MA, Mirantes C, Eritja N, Felip I, Navaridas R, Gatius S, Santacana M, Colàs E, Moiola C, Schoenenberger JA, Encinas M, Garí E, Matias-Guiu X, Dolcet X (2017) Palbociclib has antitumour effects on pten-deficient endometrial neoplasias. J Pathol 242:152–164

    Article  CAS  PubMed  Google Scholar 

  18. Zola P, Ciccone G, Piovano EP et al (2021) Intensive versus minimalist follow-up in patients treated for endometrial cancer: a multicentric randomized controlled trial (the TOTEM study—NCT00916708). J Clin Oncol 39(15):5506

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frauenklinik Barmbek, Rübenkamp 220, 22307, Hamburg, Deutschland

    Gerhard Gebauer

  2. Universitätsfrauenklinik Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland

    Tanja N. Fehm

Authors
  1. Gerhard Gebauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tanja N. Fehm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gerhard Gebauer.

Ethics declarations

Interessenkonflikt

G. Gebauer und T.N. Fehm geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

Tanja Fehm, Düsseldorf

Ludwig Kiesel, Münster

Rainer Kimmig, Essen

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gebauer, G., Fehm, T.N. Neue Aspekte in Diagnostik und Therapie des Endometriumkarzinoms. Gynäkologe 55, 211–214 (2022). https://doi.org/10.1007/s00129-022-04912-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-022-04912-x

Search

Navigation